Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain
Abstract Background Multiple sclerosis (MS) is an immune-mediated, chronic inflammatory, and demyelinating disease of the central nervous system (CNS). Several cytokines are thought to be involved in the regulation of MS pathogenesis. We recently identified interleukin (IL)-9 as a cytokine reducing...
Main Authors: | Gloria Donninelli, Inbar Saraf-Sinik, Valentina Mazziotti, Alessia Capone, Maria Grazia Grasso, Luca Battistini, Richard Reynolds, Roberta Magliozzi, Elisabetta Volpe |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12974-020-01770-z |
Similar Items
-
The Role of Interleukin-9 in Asthma
by: Hans-Peter Hauber, et al.
Published: (2005-01-01) -
Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma
by: Rahim Farahani, et al.
Published: (2014-01-01) -
Mogroside IIE Inhibits Digestive Enzymes via Suppression of Interleukin 9/Interleukin 9 Receptor Signalling in Acute Pancreatitis
by: Juan Xiao, et al.
Published: (2020-06-01) -
Interleukin-35 Suppresses Interleukin-9-Secreting CD4+ T Cell Activity in Patients With Hepatitis B-Related Hepatocellular Carcinoma
by: Qian Zhang, et al.
Published: (2021-06-01) -
Interleukin-6 and interleukin-10 gene polymorphisms and the risk of further periodontal disease progression
by: Georgios Chatzopoulos, et al.
Published: (2018-03-01)